CRYSTAL ADAM (President, R&D) sold 18.9% of their position (27K shares) of TANGO THERAPEUTICS, INC. on the open market
Open‑market sale worth $617.6K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 6/3/2026ACC: 0001193125-26-255940
Officer· President, R&D
Since Feb 2026
-27K
Net shares
Net seller
$617.6K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
27K acquired · 54K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+27K
Price / share
$5.20
Trade value
$140.40K
% of position
23.3%
6/1/2026
115.74K→142.74K
Common Stock
Direct
Shares
−6.14K
Price / share
$22.25
Trade value
$136.63K
% of position
4.3%
6/1/2026
142.74K→136.60K
Common Stock
Direct
Shares
−20.86K
Price / share
$23.06
Trade value
$480.94K
% of position
15.3%
6/1/2026
136.60K→115.74K
Total
Net shares
+0.00
Net value
-$477.17K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/1/2026 | M · Option Exercise | +27K | $5.20 | $140.40K | 23.3% | 115.74K | 142.74K |
| Common Stock Direct | 6/1/2026 | S · Sale | −6.14K | $22.25 | $136.63K | 4.3% | 142.74K | 136.60K |
| Common Stock Direct | 6/1/2026 | S · Sale | −20.86K | $23.06 | $480.94K | 15.3% | 136.60K | 115.74K |
| Total | +0.00 | -$477.17K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
27K shares
Shares
−27K
Strike price
5.2
Held after
341.04K
Exercisable
—
6/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock27K shares | 6/1/2026 | M · Option Exercise | −27K | 5.2 | — | 341.04K |